Note 18 - Commitments and Contingencies

9 Months Ended

Feb. 28, 2017

Commitments and Contingencies Disclosure [Text Block]

18.	COMMITMENTS AND CONTINGENCIES

Legal Proceedings

Immucor and BioArray Solutions Limited (“BioArray”), a wholly owned subsidiary of Immucor, are defendants in an action brought in

August

2014

by Rutgers, the State University of New Jersey (“Rutgers”), in the Superior Court of New Jersey for Middlesex County, alleging breach of contract and fraud claims under a patent license between Rutgers and BioArray. The Company has removed the case to the United States District Court for the District of New Jersey, and the plaintiffs are seeking to remand the case back to state court. The Company believes the claims are without merit and that it has meritorious defenses. While the Company believes the amount of any liability resulting from this claim is unlikely and cannot be estimated at this time, the Company does not expect any potential liability would be material to the Company

’s operations or to its financial condition.

From time to time the Company is a party to certain legal proceedings in the ordinary course of business. However, the Company is not currently subject to any legal proceedings expected to have a material adverse effect on its consolidated financial position, result of operations or cash flow.

Purchase Commitments

Purchase commitments made in the normal course of business were

$36.1

million as of

February

28,

2017.

These purchases were primarily for inventory items. The following is a schedule of the approximate future payments for purchase commitments as of

February

28,

2017

(in thousands):

Year ended May 31:
2017	$	10,831
2018		12,705
2019		7,337
2020		3,498
2021		1,750
Total	$	36,121